| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 40.59B | 40.01B | 41.43B | 39.64B | 37.50B | 34.90B |
| Gross Profit | 10.24B | 10.31B | 10.57B | 9.96B | 9.78B | 9.06B |
| EBITDA | 2.19B | 2.27B | 2.82B | 2.66B | 2.41B | 1.96B |
| Net Income | 490.00M | 597.00M | 1.22B | 1.16B | 855.00M | 648.00M |
Balance Sheet | ||||||
| Total Assets | 38.60B | 38.71B | 36.73B | 34.46B | 34.15B | 32.73B |
| Cash, Cash Equivalents and Short-Term Investments | 3.39B | 4.83B | 4.37B | 5.05B | 4.47B | 4.54B |
| Total Debt | 7.59B | 7.26B | 4.99B | 2.83B | 3.38B | 3.87B |
| Total Liabilities | 18.62B | 18.88B | 17.27B | 16.76B | 17.17B | 16.69B |
| Stockholders Equity | 19.78B | 19.67B | 19.36B | 17.62B | 16.99B | 16.04B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.35B | -2.17B | 1.51B | 865.00M | 3.76B |
| Operating Cash Flow | 0.00 | 214.00M | -284.00M | 2.42B | 1.93B | 4.60B |
| Investing Cash Flow | 0.00 | -1.45B | -2.02B | -786.00M | -1.06B | -829.00M |
| Financing Cash Flow | 0.00 | 1.50B | 1.62B | -1.11B | -998.00M | -1.79B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥16.40B | 10.34 | ― | 3.49% | -1.36% | 5.14% | |
74 Outperform | ¥28.25B | 15.61 | ― | 4.45% | -4.23% | -1.63% | |
65 Neutral | ¥4.37B | 10.76 | ― | 2.47% | -18.59% | -22.05% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥9.66B | 11.52 | ― | 3.77% | ― | ― | |
45 Neutral | ¥43.57B | 26.74 | ― | 1.55% | 10.90% | ― | |
43 Neutral | ¥16.23B | -2.58 | ― | 5.41% | -2.22% | 18.80% |